ENCODE biosample ENCBS420NOS

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS420NOS: human_brain_Rush ID_E7623847_BS163_ENC4_cDNA713


ENCODE biosample ENCBS422TMB

status: PUBLIC

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 90 or above year

tag: attribute

characteristic: age

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

text: ENCODE biosample ENCBS422TMB: human_brain_Rush ID_7948794_BS24_ENC4_cDNA657

characteristic: title


ENCODE biosample ENCBS425RTI

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS15A

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS425RTI: RNA-seq on K562 cells treated with a CRISPR gRNA against RPS15A. (RPS15A-BGKcLV30-68)


ENCODE biosample ENCBS426DQB

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 25 uM Galeterone for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS426DQB: RNA-seq on human cell line K562

text: treatment_term_name: Galeterone; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS426GBU

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDK9

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS426GBU: RNA-seq on K562 cells treated with a CRISPR gRNA against CDK9. (CDK9-BGKcLV28-13)


ENCODE biosample ENCBS426VMT

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS426VMT: Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV31-1)

characteristic: title


ENCODE biosample ENCBS427YHC

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 10 uM Crizotinib for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS427YHC: RNA-seq on human cell line K562

text: treatment_term_name: Crizotinib; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS428HIV

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line treated with 100 nM GSK J4 for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS428HIV: RNA-seq on human cell line K562

text: treatment_term_name: GSK J4; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS428JUW

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens LARS

characteristic: description

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS428JUW: RNA-seq on HepG2 cells treated with a CRISPR gRNA against LARS. (LARS-BGHcLV24-35)


ENCODE biosample ENCBS428TND

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RNH1

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS428TND: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RNH1. (RNH1-BGHcLV32-38)

characteristic: title


ENCODE biosample ENCBS429CMY

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 50 uM C646 for 4 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS429CMY: RNA-seq on human cell line K562

text: treatment_term_name: C646; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS429YTL

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CNOT2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS429YTL: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CNOT2. (CNOT2-BGHcLV24-21)


ENCODE biosample ENCBS430SUA

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS430SUA: human_brain_Rush ID_E4205723_BS199_ENC4_cDNA754


ENCODE biosample ENCBS430TYQ

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 22 year

text: activated B cell

characteristic: cell type

text: Homo sapiens male adult (22 years) activated B primary cell treated with 0.5 uM CpG ODN for 24 hours

text: adult

characteristic: donor ID

text: Yijun Ruan, JAX

text: Homo sapiens

characteristic: organism

text: primary cell

text: male

text: AllCells

characteristic: source

text: ENCODE biosample ENCBS430TYQ

characteristic: title

text: treatment_term_name: CpG ODN; treatment_type: chemical; duration: 24; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS430ULM

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CARHSP1

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS430ULM: RNA-seq on K562 cells treated with a CRISPR gRNA against CARHSP1. (CARHSP1-BGKcLV26-55)


ENCODE biosample ENCBS431HLD

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 83 year

characteristic: age

text: Homo sapiens female adult (83 years) with mild cognitive impairment; middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS431HLD: human_brain_Rush ID_8282759_BS106_ENC4_cDNA660


ENCODE biosample ENCBS433QBR

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 55 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (55 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

characteristic: donor ID

text: Healthy donor

text: Michael Snyder, Stanford

text: Homo sapiens

characteristic: organism

text: in vitro differentiated cells

text: male

text: Cooper-Knock lab, University of Sheffield, UK

characteristic: source

text: ENCODE biosample ENCBS433QBR: RNA-seq on human

characteristic: title


ENCODE biosample ENCBS433VQN

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 10 uM AR-42 for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS433VQN: RNA-seq on human cell line K562

text: treatment_term_name: AR-42; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS434SCV

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 25 year

characteristic: age

text: Homo sapiens Calu3 cell line, subjected to a 6 hour pulse-chase

characteristic: description

text: adult

characteristic: dev stage

text: Lung adenocarcinoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS434SCV


ENCODE biosample ENCBS436WHA

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS436WHA: human_brain_Rush ID_4933693_BS56_ENC4_cDNA652

characteristic: title


ENCODE biosample ENCBS439FJF

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 87 year

text: Homo sapiens female adult (87 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS439FJF: human_brain_Rush ID_E6090948_BS101_ENC4_cDNA678


ENCODE biosample ENCBS440YTE

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

characteristic: age

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CTCF

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS440YTE


ENCODE biosample ENCBS441GXQ

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours

characteristic: description

text: adult

characteristic: dev stage

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS441GXQ: HL-60 derived M0 macrophages

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS441RWM

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 30 year

text: Homo sapiens WTC11 cell line, preserved by flash-freezing

text: adult

characteristic: donor ID

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: Coriell

characteristic: source

text: ENCODE biosample ENCBS441RWM: iPSC

characteristic: title


ENCODE biosample ENCBS442FVR

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 47 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (47 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

text: Donor with Amyotrophic Lateral Sclerosis

text: Michael Snyder, Stanford

characteristic: lab

text: Homo sapiens

text: in vitro differentiated cells

text: male

text: ENCODE biosample ENCBS442FVR: RNA-seq on human


ENCODE biosample ENCBS443SUX

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 58 year

characteristic: age

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM GW870086 (agonist) for 4 hours

characteristic: description

text: adult

characteristic: dev stage

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS443SUX

text: treatment_term_name: GW870086; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS444BPA

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SCAF8

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS444BPA: RNA-seq on K562 cells treated with a CRISPR gRNA against SAMHD1. (SAMHD1-BGKcLV33-27)


ENCODE biosample ENCBS446TXU

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPL29

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS446TXU: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPL29. (RPL29-BGHcLV32-46)

characteristic: title


ENCODE biosample ENCBS447TCM

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens MED14 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS447TCM

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS448MDY

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 58 year

characteristic: age

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM dexamethasone (agonist) for 4 hours

characteristic: description

text: adult

characteristic: dev stage

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS448MDY

text: treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS448YLZ

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SF3A2

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS448YLZ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SF3A2. (SF3A2-BGHcLV24-48)


ENCODE biosample ENCBS450LGX

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDV3

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS450LGX: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CDV3. (CDV3-BGHcLV29-16)

characteristic: title


ENCODE biosample ENCBS451EGX

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEC63

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS451EGX: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SEC63. (SEC63-BGHcLV31-38)


ENCODE biosample ENCBS452OHN

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 58 year

characteristic: age

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM CpdA (agonist) for 4 hours

characteristic: description

text: adult

characteristic: dev stage

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS452OHN

text: treatment_term_name: CpdA; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS455JAT

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 15 year

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS455JAT: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPL29. (RPL29-BGHcLV32-45)


ENCODE biosample ENCBS456UIQ

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAT

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS456UIQ: RNA-seq on K562 cells treated with a CRISPR gRNA against CAT. (CAT-BGKcLV26-62)

characteristic: title


ENCODE biosample ENCBS458NJP

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CNDP2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS458NJP: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CNDP2. (CNDP2-BGHcLV29-28)


ENCODE biosample ENCBS458UWG

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF4

characteristic: description

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS458UWG: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CPSF4. (CPSF4-BGHcLV24-23)


ENCODE biosample ENCBS459VZX

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS459VZX: human_brain_Rush ID_E5841627_BS204_ENC4_cDNA759


ENCODE biosample ENCBS462HZR

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS462HZR: Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV27-2)

characteristic: title


ENCODE biosample ENCBS462NYH

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEC62

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS462NYH: RNA-seq on K562 cells treated with a CRISPR gRNA against SCAF8. (SCAF8-BGKcLV33-34)


ENCODE biosample ENCBS465EAG

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SUPT16H

characteristic: description

text: adult

characteristic: dev stage

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS465EAG


ENCODE biosample ENCBS466IYK

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 30 year

text: Homo sapiens WTC11 cell line, preserved by flash-freezing

text: adult

characteristic: donor ID

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: Coriell

text: ENCODE biosample ENCBS466IYK: iPSC


ENCODE biosample ENCBS471JPC

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ATXN2L

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS471JPC: RNA-seq on K562 cells treated with a CRISPR gRNA against ATXN2L. (ATXN2L-BGKcLV26-40)

characteristic: title


ENCODE biosample ENCBS472HJD

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

text: Ali Mortazavi, UCI

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS472HJD: K562


ENCODE biosample ENCBS477EBR

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 7.5 nM Panobinostat for 24 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS477EBR: RNA-seq on human cell line K562

text: treatment_term_name: Panobinostat; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS478QMB

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ACO2

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS478QMB: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ACO2. (ACO2-BGHcLV25-4)


ENCODE biosample ENCBS479ZAJ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS479ZAJ: human_brain_Rush ID_E8973904_BS189_ENC4_cDNA743

characteristic: title


ENCODE biosample ENCBS480AAL

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDV3

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS480AAL: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CDV3. (CDV3-BGHcLV29-15)


ENCODE biosample ENCBS481KCJ

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS481KCJ: human_brain_Rush ID_E8505753_BS213_ENC4_cDNA768


ENCODE biosample ENCBS481PFI

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens MTREX

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS481PFI: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SKIV2L2. (SKIV2L2-BGHcLV31-4)


ENCODE biosample ENCBS481WHG

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 90 or above year

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS481WHG: human_brain_Rush ID_6207143_BS26_ENC4_cDNA655

characteristic: title


ENCODE biosample ENCBS485BXU

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 88 year

characteristic: age

text: Homo sapiens female adult (88 years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS485BXU: human_brain_Rush ID_E8259623_BS127_ENC4_cDNA689


ENCODE biosample ENCBS485QLG

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SUPT16H treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

characteristic: description

text: adult

characteristic: dev stage

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS485QLG

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS486BLT

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens APEH

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS486BLT: RNA-seq on HepG2 cells treated with a CRISPR gRNA against APEH. (APEH-BGHcLV27-10)


ENCODE biosample ENCBS486IFU

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens POLR2A treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS486IFU

characteristic: title


ENCODE biosample ENCBS486RRL

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 58 year

characteristic: age

text: Homo sapiens A549 cell line treated with 1 uM RU486 (agonist) for 4 hours

characteristic: description

text: adult

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS486RRL

text: treatment_term_id: CHEBI:50692; treatment_term_name: RU486; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS486WPL

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 10 ng/mL interleukin-13 for 24 hours, 10 ng/mL interleukin-4 for 24 hours

text: adult

characteristic: dev stage

text: acute promyelocytic leukemia

characteristic: health state

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS486WPL: HL-60 derived M2A macrophages (24hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: UniProtKB:P35225; treatment_term_name: interleukin-13; treatment_type: protein; duration: 24; duration_units: hour; treatment_term_id: UniProtKB:P05112; treatment_term_name: interleukin-4; treatment_type: protein; duration: 24; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS488HJZ

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens BRD4 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS488HJZ


ENCODE biosample ENCBS488OTG

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CWF19L2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS488OTG: RNA-seq on K562 cells treated with a CRISPR gRNA against CWF19L2. (CWF19L2-BGKcLV28-56)

characteristic: title


ENCODE biosample ENCBS491OPF

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 100 nM GSK J4 for 24 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS491OPF: RNA-seq on human cell line K562

text: treatment_term_name: GSK J4; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS492BTH

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CCT2

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS492BTH: RNA-seq on K562 cells treated with a CRISPR gRNA against CCT2. (CCT2-BGKcLV28-3)


ENCODE biosample ENCBS492ELW

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 86 year

text: Homo sapiens female adult (86 years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS492ELW: human_brain_Rush ID_E1652886_BS174_ENC4_cDNA728


ENCODE biosample ENCBS492EVY

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ATP5F1A

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS492EVY: RNA-seq on K562 cells treated with a CRISPR gRNA against ATP5A1. (ATP5A1-BGKcLV26-38)

characteristic: title


ENCODE biosample ENCBS497REY

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 48 year

characteristic: age

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens POLR2A treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

characteristic: description

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS497REY

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS497SRU

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 48 year

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS497SRU


ENCODE biosample ENCBS500BTR

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPUSD2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS500BTR: RNA-seq on K562 cells treated with a CRISPR gRNA against SKIV2L2. (SKIV2L2-BGKcLV33-10)


ENCODE biosample ENCBS500QUI

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 78 year

characteristic: age

text: Homo sapiens female adult (78 years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS500QUI: human_brain_Rush ID_E2229963_BS176_ENC4_cDNA730

characteristic: title


ENCODE biosample ENCBS502BBM

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 36 year

text: MCF 10A

text: Homo sapiens MCF 10A cell line, subjected to a 2 hour pulse-chase

characteristic: description

text: adult

text: fibrocystic disease

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS502BBM


ENCODE biosample ENCBS502VJO

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADK

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS502VJO: RNA-seq on K562 cells treated with a CRISPR gRNA against ADK. (ADK-BGKcLV26-11)


ENCODE biosample ENCBS504GSS

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADAT3

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS504GSS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ADAT3. (ADAT3-BGHcLV24-8)


ENCODE biosample ENCBS504PDX

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

text: 89 year

characteristic: age

text: Homo sapiens female adult (89 years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS504PDX: human_brain_Rush ID_E7908427_BS211_ENC4_cDNA766

characteristic: title


ENCODE biosample ENCBS504VVD

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEC62

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS504VVD: RNA-seq on K562 cells treated with a CRISPR gRNA against SCAF8. (SCAF8-BGKcLV33-33)


ENCODE biosample ENCBS505KRY

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 31 year

text: Homo sapiens male adult (31 years) heart left ventricle tissue, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: healthy

characteristic: health state

text: Michael Snyder, Stanford

text: Homo sapiens

text: tissue

text: male

text: Shin Lin

text: heart left ventricle

text: ENCODE biosample ENCBS505KRY: Homo sapiens heart left ventricle tissue


ENCODE biosample ENCBS506TDA

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

text: 87 year

text: Homo sapiens male adult (87 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: male

characteristic: sex

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS506TDA: human_brain_Rush ID_E3291783_BS154_ENC4_cDNA704


ENCODE biosample ENCBS508PAK

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 19 year

characteristic: age

text: mammary epithelial cell

characteristic: cell type

text: Homo sapiens female adult (19 years) mammary epithelial primary cell, subjected to a 2 hour pulse-chase

text: adult

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: primary cell

text: female

text: Lonza

characteristic: source

text: ENCODE biosample ENCBS508PAK

characteristic: title


ENCODE biosample ENCBS509BGS

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens API5

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS509BGS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against API5. (API5-BGHcLV27-11)


ENCODE biosample ENCBS511GAV

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 30 year

text: Homo sapiens WTC11 cell line, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS511GAV: iPSC


ENCODE biosample ENCBS511LEK

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line treated with 25 uM Galeterone for 4 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS511LEK: RNA-seq on human cell line K562

text: treatment_term_name: Galeterone; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS511MHE

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 48 year

characteristic: age

text: Homo sapiens OCI-LY7 cell line treated with 500 rad irradiation

text: adult

text: B cell lymphoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: male

text: DSMZ

characteristic: source

text: ENCODE biosample ENCBS511MHE

characteristic: title

text: treatment_term_name: irradiation; treatment_type: irradiation;


ENCODE biosample ENCBS512BUS

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF7

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS512BUS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CPSF7. (CPSF7-BGHcLV29-40)


ENCODE biosample ENCBS512NDV

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AGFG1

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS512NDV: RNA-seq on HepG2 cells treated with a CRISPR gRNA against AGFG1. (AGFG1-BGHcLV25-19)


ENCODE biosample ENCBS513DCS

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens BRIX1

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS513DCS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against BRIX1. (BRIX1-BGHcLV24-20)


ENCODE biosample ENCBS514PFB

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS514PFB: K562

characteristic: title


ENCODE biosample ENCBS515ZUG

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DDX18

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS515ZUG: RNA-seq on K562 cells treated with a CRISPR gRNA against DDX18. (DDX18-BGKcLV28-72)


ENCODE biosample ENCBS517FMR

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line treated with 10 uM AR-42 for 12 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS517FMR: RNA-seq on human cell line K562

text: treatment_term_name: AR-42; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS518YBV

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SNW1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS518YBV: RNA-seq on K562 cells treated with a CRISPR gRNA against SMG9. (SMG9-BGKcLV33-62)


ENCODE biosample ENCBS519MHE

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 30 year

characteristic: age

text: Homo sapiens WTC11 cell line

text: adult

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: male

text: Coriell

characteristic: source

text: ENCODE biosample ENCBS519MHE

characteristic: title


ENCODE biosample ENCBS520OTA

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 49 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (49 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

characteristic: description

text: adult

text: Donor with Amyotrophic Lateral Sclerosis

text: Michael Snyder, Stanford

text: Homo sapiens

text: in vitro differentiated cells

text: male

text: Cooper-Knock lab, University of Sheffield, UK

text: ENCODE biosample ENCBS520OTA: RNA-seq on human


ENCODE biosample ENCBS525YTW

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM Mapracorat (agonist) for 4 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS525YTW

text: treatment_term_id: CHEBI:177650; treatment_term_name: Mapracorat; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS526RIS

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: John Lis, Cornell

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS526RIS


ENCODE biosample ENCBS528FQJ

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CLNS1A

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS528FQJ: RNA-seq on K562 cells treated with a CRISPR gRNA against CLNS1A. (CLNS1A-BGKcLV28-22)

characteristic: title


ENCODE biosample ENCBS529AZE

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS529AZE: Control CRISPR gRNA against no target in K562 cells followed by RNA-seq. (NT-BGKcLV30-2)


ENCODE biosample ENCBS530FWA

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens C1QBP

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS530FWA: RNA-seq on HepG2 cells treated with a CRISPR gRNA against C1QBP. (C1QBP-BGHcLV27-32)


ENCODE biosample ENCBS530WHW

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 72 year

text: Homo sapiens Caco-2 cell line, subjected to a 2 hour pulse-chase

text: adult

text: colorectal adenocarcinoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS530WHW


ENCODE biosample ENCBS531BSW

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 22 year

characteristic: age

text: B cell

characteristic: cell type

text: Homo sapiens male adult (22 years) B primary cell

text: adult

text: Yijun Ruan, JAX

text: Homo sapiens

text: primary cell

text: male

text: AllCells

characteristic: source

text: ENCODE biosample ENCBS531BSW

characteristic: title


ENCODE biosample ENCBS533HEV

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SMG5

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS533HEV: RNA-seq on K562 cells treated with a CRISPR gRNA against SF3B2. (SF3B2-BGKcLV33-51)


ENCODE biosample ENCBS533MTK

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 22 year

text: B cell

text: adult

characteristic: donor ID

text: Yijun Ruan, JAX

characteristic: lab

text: Homo sapiens

text: primary cell

text: male

text: AllCells

text: ENCODE biosample ENCBS533MTK


ENCODE biosample ENCBS534SPQ

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 36 year

text: MCF 10A

text: Homo sapiens MCF 10A cell line

text: adult

text: fibrocystic disease

characteristic: health state

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS534SPQ


ENCODE biosample ENCBS535FPO

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DDX17

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS535FPO: RNA-seq on K562 cells treated with a CRISPR gRNA against DDX17. (DDX17-BGKcLV28-69)

characteristic: title


ENCODE biosample ENCBS535IUJ

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DCTN2

characteristic: description

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS535IUJ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against DCTN2. (DCTN2-BGHcLV29-66)


ENCODE biosample ENCBS536HUT

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 10 nM Bortezomib for 48 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS536HUT: RNA-seq on human cell line K562

text: treatment_term_id: CHEBI:52717; treatment_term_name: Bortezomib; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS537UUI

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CCT4

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS537UUI: RNA-seq on K562 cells treated with a CRISPR gRNA against CCT4. (CCT4-BGKcLV28-8)


ENCODE biosample ENCBS538QLS

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 19 year

characteristic: age

text: mammary epithelial cell

characteristic: cell type

text: Homo sapiens female adult (19 years) mammary epithelial primary cell, subjected to a 6 hour pulse-chase

text: adult

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: primary cell

text: female

text: Lonza

characteristic: source

text: ENCODE biosample ENCBS538QLS

characteristic: title


ENCODE biosample ENCBS538TKB

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 36 year

characteristic: cell line

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 10 ng/mL interleukin-13 for 72 hours, 10 ng/mL interleukin-4 for 72 hours

characteristic: description

text: adult

characteristic: dev stage

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS538TKB: HL-60 derived M2A macrophages (72hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: UniProtKB:P35225; treatment_term_name: interleukin-13; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:P05112; treatment_term_name: interleukin-4; treatment_type: protein; duration: 72; duration_units: hour;


ENCODE biosample ENCBS539IOW

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens API5

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS539IOW: RNA-seq on K562 cells treated with a CRISPR gRNA against API5. (API5-BGKcLV26-27)


ENCODE biosample ENCBS539OCN

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM28

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS539OCN: RNA-seq on K562 cells treated with a CRISPR gRNA against RBM28. (RBM28-BGKcLV30-17)


ENCODE biosample ENCBS540BVM

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS540BVM: human_brain_Rush ID_E3439501_BS153_ENC4_cDNA703

characteristic: title


ENCODE biosample ENCBS540NPH

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPL29

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS540NPH: RNA-seq on K562 cells treated with a CRISPR gRNA against RPL29. (RPL29-BGKcLV30-47)


ENCODE biosample ENCBS540RKF

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SMARCA5 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: donor ID

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS540RKF

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS542MKJ

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 7.5 nM Vorinostat for 4 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS542MKJ: RNA-seq on human cell line K562

text: treatment_term_name: Vorinostat; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS542OFI

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 73 year

text: Homo sapiens male adult (73 years) with Alzheimer's disease, Cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: male

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS542OFI: human_brain_Rush ID_1764669_BS90_ENC4_cDNA667

characteristic: title


ENCODE biosample ENCBS543AIH

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CSE1L

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS543AIH: RNA-seq on K562 cells treated with a CRISPR gRNA against CSE1L. (CSE1L-BGKcLV28-43)


ENCODE biosample ENCBS544WUH

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 90 or above year

text: Homo sapiens male adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

characteristic: organism

text: tissue

text: male

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS544WUH: human_brain_Rush ID_E7886851_BS164_ENC4_cDNA714


ENCODE biosample ENCBS545PYF

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 83 year

characteristic: age

text: Homo sapiens male adult (83 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: male

characteristic: sex

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS545PYF: human_brain_Rush ID_E7404786_BS166_ENC4_cDNA716


ENCODE biosample ENCBS546CBA

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 47 year

text: Homo sapiens female adult (47 years) heart left ventricle tissue, preserved by flash-freezing

text: adult

text: healthy

text: Michael Snyder, Stanford

text: Homo sapiens

text: tissue

text: female

text: Shin Lin

characteristic: source

text: heart left ventricle

characteristic: tissue

text: ENCODE biosample ENCBS546CBA: Homo sapiens heart left ventricle tissue

characteristic: title


ENCODE biosample ENCBS547LXE

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEC23IP

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS547LXE: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SEC23IP. (SEC23IP-BGHcLV31-32)


ENCODE biosample ENCBS550JRC

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RTCB

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS550JRC: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RTCB. (RTCB-BGHcLV31-17)


ENCODE biosample ENCBS554PHI

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 87 year

characteristic: age

text: Homo sapiens male adult (87 years) with Cognitive impairment, Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: male

characteristic: sex

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS554PHI: human_brain_Rush ID_E2541828_BS179_ENC4_cDNA733


ENCODE biosample ENCBS555RZQ

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM RU486 (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS555RZQ

characteristic: title

text: treatment_term_id: CHEBI:50692; treatment_term_name: RU486; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS555TAR

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DDX17

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS555TAR: RNA-seq on K562 cells treated with a CRISPR gRNA against DDX17. (DDX17-BGKcLV28-70)


ENCODE biosample ENCBS556EEU

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM CpdA (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS556EEU

text: treatment_term_name: CpdA; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS556WPL

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RUVBL1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS556WPL: RNA-seq on K562 cells treated with a CRISPR gRNA against RPUSD2. (RPUSD2-BGKcLV33-17)


ENCODE biosample ENCBS558TFT

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SPAG9

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS558TFT: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SPAG9. (SPAG9-BGHcLV31-64)

characteristic: title


ENCODE biosample ENCBS559VPJ

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RNASEH2A

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS559VPJ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RNASEH2A. (RNASEH2A-BGHcLV32-35)


ENCODE biosample ENCBS561VWT

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CARHSP1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS561VWT: RNA-seq on K562 cells treated with a CRISPR gRNA against CARHSP1. (CARHSP1-BGKcLV26-56)


ENCODE biosample ENCBS562WXY

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 7.5 nM Panobinostat for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS562WXY: RNA-seq on human cell line K562

text: treatment_term_name: Panobinostat; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS563NAX

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM Mapracorat (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS563NAX

characteristic: title

text: treatment_term_id: CHEBI:177650; treatment_term_name: Mapracorat; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS565EUZ

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 7.5 nM Vorinostat for 48 hours, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS565EUZ: RNA-seq on human cell line K562

text: treatment_term_name: Vorinostat; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS568BYI

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 72 year

text: Homo sapiens Caco-2 cell line

text: adult

text: colorectal adenocarcinoma

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS568BYI


ENCODE biosample ENCBS568KMK

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SMG8

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS568KMK: RNA-seq on K562 cells treated with a CRISPR gRNA against SMG5. (SMG5-BGKcLV33-56)


ENCODE biosample ENCBS572GTT

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SNUPN

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS572GTT: RNA-seq on K562 cells treated with a CRISPR gRNA against SMG8. (SMG8-BGKcLV33-60)

characteristic: title


ENCODE biosample ENCBS573XPO

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM DMSO (agonist) for 4 hours

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS573XPO

text: treatment_term_id: CHEBI:28262; treatment_term_name: DMSO; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS575OYH

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS575OYH: human_brain_Rush ID_E9620322_BS190_ENC4_cDNA744


ENCODE biosample ENCBS576FYS

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 1% DMSO for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS576FYS: RNA-seq on human cell line K562

text: treatment_term_name: DMSO; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS577UDQ

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 90 or above year

text: Homo sapiens male adult (90 or above years) middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: male

characteristic: sex

text: Rush University

characteristic: source

text: middle frontal area 46

text: ENCODE biosample ENCBS577UDQ: human_brain_Rush ID_E6413534_BS158_ENC4_cDNA708

characteristic: title


ENCODE biosample ENCBS578OIT

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 41 year

text: natural killer cell

characteristic: cell type

text: Homo sapiens female adult (41 years) natural killer primary cell

text: adult

characteristic: dev stage

characteristic: donor ID

text: John Stamatoyannopoulos, UW

text: Homo sapiens

text: primary cell

text: female

text: StemExpress

text: ENCODE biosample ENCBS578OIT


ENCODE biosample ENCBS580XHX

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 25 uM Galeterone for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS580XHX: RNA-seq on human cell line K562

text: treatment_term_name: Galeterone; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS586NYG

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SMG7

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS586NYG: RNA-seq on K562 cells treated with a CRISPR gRNA against SF3B3. (SF3B3-BGKcLV33-53)


ENCODE biosample ENCBS589OUP

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 89 year

text: Homo sapiens male adult (89 years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: male

characteristic: sex

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS589OUP: human_brain_Rush ID_E8792932_BS215_ENC4_cDNA770

characteristic: title


ENCODE biosample ENCBS590JCA

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM14

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS590JCA: RNA-seq on K562 cells treated with a CRISPR gRNA against RBM14. (RBM14-BGKcLV30-6)


ENCODE biosample ENCBS590OGF

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 72 year

characteristic: age

text: Homo sapiens Caco-2 cell line, subjected to a 2 hour pulse-chase

characteristic: description

text: adult

text: colorectal adenocarcinoma

characteristic: health state

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS590OGF


ENCODE biosample ENCBS591EWF

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 36 year

text: MCF 10A

text: Homo sapiens MCF 10A cell line treated with 500 rad irradiation

text: adult

text: fibrocystic disease

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS591EWF

text: treatment_term_name: irradiation; treatment_type: irradiation;

characteristic: treatments


ENCODE biosample ENCBS592HZY

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: Homo sapiens PC-9 cell line, subjected to a 2 hour pulse-chase

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: not collected

text: Sigma

characteristic: source

text: ENCODE biosample ENCBS592HZY

characteristic: title


ENCODE biosample ENCBS592LWX

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 48 year

characteristic: age

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CTCF treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS592LWX

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS593HDZ

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ACTN4

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS593HDZ: RNA-seq on K562 cells treated with a CRISPR gRNA against ACTN4. (ACTN4-BGKcLV26-6)


ENCODE biosample ENCBS593LYT

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 50 uM C646 for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS593LYT: RNA-seq on human cell line K562

text: treatment_term_name: C646; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS593WOX

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

text: naive thymus-derived CD4-positive, alpha-beta T cell

characteristic: cell type

text: Homo sapiens male adult (48 years) naive thymus-derived CD4-positive, alpha-beta T primary cell

text: adult

text: John Stamatoyannopoulos, UW

text: Homo sapiens

text: primary cell

text: male

text: StemExpress

characteristic: source

text: ENCODE biosample ENCBS593WOX

characteristic: title


ENCODE biosample ENCBS594GCK

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 58 year

characteristic: age

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM Hydrocortisone (agonist) for 4 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS594GCK

text: treatment_term_id: CHEBI:17650; treatment_term_name: Hydrocortisone; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS596ENC

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: Homo sapiens male prostate gland tissue

characteristic: description

text: Thomas Gingeras, CSHL

characteristic: lab

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: male

text: Ambion

text: prostate gland

characteristic: tissue

text: ENCODE biosample ENCBS596ENC: prostate tissue purchased for CSHL project


ENCODE biosample ENCBS596YYF

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CTCF

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS596YYF


ENCODE biosample ENCBS597FPH

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 30 year

characteristic: age

text: Homo sapiens WTC11 cell line, preserved by flash-freezing

text: adult

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

characteristic: source

text: ENCODE biosample ENCBS597FPH: iPSC

characteristic: title


ENCODE biosample ENCBS598YTE

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CD3EAP

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS598YTE: RNA-seq on K562 cells treated with a CRISPR gRNA against CD3EAP. (CD3EAP-BGKcLV28-9)


ENCODE biosample ENCBS599HZH

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 10 nM Bortezomib for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS599HZH: RNA-seq on human cell line K562

text: treatment_term_id: CHEBI:52717; treatment_term_name: Bortezomib; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS600HFC

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM AZD2906 (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS600HFC

text: treatment_term_name: AZD2906; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS601WBA

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 10 uM Crizotinib for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS601WBA: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: Crizotinib; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS603SIB

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM26

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS603SIB: RNA-seq on K562 cells treated with a CRISPR gRNA against RBM26. (RBM26-BGKcLV30-13)


ENCODE biosample ENCBS603YYY

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SUPT16H

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS603YYY